WCN24-701 EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON PLASMA LEVELS OF UREMIC TOXINS IN PATIENTS UNDERGOING HEMODIALYSIS

WCN24-701 EFFECTS OF SULFORAPHANE SUPPLEMENTATION ON PLASMA LEVELS OF UREMIC TOXINS IN PATIENTS UNDERGOING HEMODIALYSIS

Saved in:

Bibliographic Details
Main Authors:	Denise Mafra, Marcia Ribeiro, Livia Alvarenga, Ludmila Cardozo, Lia Nakao, Marcelo Ribeiro-Alves, Julie Ann Kemp
Format:	Article
Language:	English
Published:	Elsevier 2024-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924005436
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN24-746 SUPPLEMENTATION WITH SULFORAPHANE INCREASES NRF2 mRNA EXPRESSION IN NONDIALYSIS CKD PATIENTS
by: Denise Mafra, et al.
Published: (2024-04-01)

WCN24-628 SULFORAPHANE SUPPLEMENTATION INCREASES HIGH-DENSITY LIPOPROTEIN CHOLESTEROL IN HEMODIALYSIS PATIENTS
by: Ludmila Cardozo, et al.
Published: (2024-04-01)

WCN24-1231 Propolis supplementation decreases oxLDL plasma levels in patients undergoing hemodialysis
by: Larissa Fonseca, et al.
Published: (2024-04-01)

WCN24-893 RESISTANT STARCH DOES NOT INFLUENCE LIPOPROTEIN SUBFRACTIONS PROFILE IN HEMODIALYSIS PATIENTS
by: Denise Mafra, et al.
Published: (2024-04-01)

Trimethylamine N-Oxide (TMAO) Plasma Levels in Patients with Different Stages of Chronic Kidney Disease
by: Marcia Ribeiro, et al.
Published: (2024-12-01)

Bioactive Compounds as Modulators of N-Formyl Peptide Signaling in Chronic Diseases
by: Livia Alvarenga, et al.
Published: (2025-07-01)

WCN24-2240 THE IMPACT OF INTRADIALYTIC EXERCISE AND DIALYSATE TEMPERATURE ON UREMIC TOXINS CLEARANCE IN HEMODIAFILTRATION PATIENTS
by: Ivan Zepeda-Quiroz, et al.
Published: (2024-04-01)

Future of Uremic Toxin Management
by: Raymond Vanholder, et al.
Published: (2024-10-01)

The Exposome and the Kidney: A Silent Dialogue Shaping Chronic Kidney Disease
by: Livia Alvarenga, et al.
Published: (2025-05-01)

WCN24-1200 Antioxidant effects of a mix containing Curcuma longa L. and green propolis extract on patients undergoing hemodialysis: results from a randomised clinical trial
by: Danielle Nascimento, et al.
Published: (2024-04-01)

Comparison of uremic toxin removal between expanded hemodialysis and high volume online hemodiafiltrations in different modes
by: Jan Biedunkiewicz, et al.
Published: (2024-11-01)

Hemodiafiltration with endogenous reinfusion for uremic toxin removal in patients undergoing maintenance hemodialysis: a pilot study
by: Renhua Lu, et al.
Published: (2024-12-01)

WCN24-882 PHENOTYPES OF PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME
by: Ekaterina Ivanova, et al.
Published: (2024-04-01)

Adsorption of uremic toxins over dealuminated zeolites
by: Bachar Koubaissy, et al.
Published: (2017-03-01)

Myostatin Exacerbates Endothelial Dysfunction Induced by Uremic Toxin Indoxyl Sulfate and Is Associated with Hemodialysis Arteriovenous Access Complications
by: Justine Solignac, et al.
Published: (2025-03-01)

WCN24-1027 THE ALTERNATIVE COMPLEMENT PATHWAY IN SHIGA TOXIN-PRODUCING ESCHERICHIA COLI– ASSOCIATED HEMOLYTIC UREMIC SYNDROME (STEC-HUS)
by: Patricia G. Vallés, et al.
Published: (2024-04-01)

WCN24-1000 OUTCOMES OF ATYPICAL HEMOLYTIC UREMIC SYNDROME
by: Narayan Prasad, et al.
Published: (2024-04-01)

Effects of <i>Curcuma longa</i> L. and Green Propolis Extract-Loaded Microcapsules Supplementation on Inflammation in Hemodialysis Patients: Preliminary Results of a Randomized Clinical Trial
by: Isadora Britto, et al.
Published: (2025-05-01)

Sulforaphane in experimental hypertension
by: Ali Banigesh, et al.
Published: (2020-07-01)

WCN24-2704 DEXMEDETOMIDINE, A NEW OPPORTUNITY IN UREMIC PATIENTS
by: Luz Alcantar Vallin, et al.
Published: (2024-04-01)

WCN24-797 Roles of Irisin, a myokine on uremic sarcopenia
by: Teruyuki Okuma, et al.
Published: (2024-04-01)

Transport of the uremic toxin symmetric dimethylarginine (SDMA) by renal transport proteins
by: Lorenz A. Scherpinski, et al.
Published: (2025-06-01)

Furosemide and Serum Protein-Bound Uremic Toxin Concentrations in Patients With CKD
by: Margaux Costes-Albrespic, et al.
Published: (2025-07-01)

Uremic Pericarditis with Cardiac Tamponade in a Patient on Hemodialysis
by: Nismat Javed, et al.
Published: (2023-01-01)

Application value of high flux hemodialysis in uremic elders
by: Chen Yan, et al.
Published: (2021-01-01)

WCN24-804 Intestinal dysbiosis-related uremic toxins and colon cancer: P-cresyl sulphate and Indoxyl sulphate stimulate colon cancer progression in patients with CKD
by: Mariadelina Simeoni, et al.
Published: (2024-04-01)

Role of GM-CSF in normalizing the effect of Uremic Toxins on Neutrophil Apoptosis and Function
by: Nariman Zahran, et al.
Published: (2014-08-01)

Monocytes serve as Shiga toxin carriers during the development of hemolytic uremic syndrome
by: Xinlei Sun, et al.
Published: (2025-01-01)

Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation
by: Prabhash Kumar Jha, et al.
Published: (2025-03-01)

The influence of uremic toxins on low bone turnover disease in chronic kidney disease
by: Giou-Teng Yiang, et al.
Published: (2024-01-01)

WCN24-1722 UREMIC TUMOR CALCINOSIS: A PROBLEM STILL PRESENT TODAY
by: Gustavo Gomes Thomé, et al.
Published: (2024-04-01)

WCN24-1367 DECODING THE UNCOMMON AETIOLOGY OF AN ATYPICAL HEMOLYTIC UREMIC SYNDROME CASE
by: Marina Leiva, et al.
Published: (2024-04-01)

Sulforaphane alters the acidification of the yeast vacuole
by: Alexander Wilcox, et al.
Published: (2020-03-01)

From Physicochemical Classification to Multidimensional Insights: A Comprehensive Review of Uremic Toxin Research
by: Mario Cozzolino, et al.
Published: (2025-06-01)

Microbial-Derived Uremic Toxins: Role in the Pathogenesis of Comorbidities in Patients with Chronic Kidney Disease
by: M. O. Pyatchenkov, et al.
Published: (2023-09-01)

Effectiveness of combined treatment of lanthanum carbonate and hemodialysis for uremic pruritus of skin
by: WANG You, et al.
Published: (2015-01-01)

Influence of high flux hemodialysis on microinflammatory and nutritional status of uremic patients
by: LIU Na, et al.
Published: (2017-01-01)

WCN24-1052 Knowledge and demands on palliative care and trust in the multidisciplinary Hemodialysis team
by: LIVIA MARQUES, et al.
Published: (2024-04-01)

WCN24-2163 AN ATYPICAL CAUSE OF ATYPICAL HAEMOLYTIC UREMIC SYNDROME : A CASE REPORT
by: Anaghashree Udayashankar, et al.
Published: (2024-04-01)

WCN24-2649 CALCIFIED MASSES IN A PERITONEAL DIALYSIS PATIENT: UREMIC TUMOR CALCINOSIS
by: Claudia Alexandra Cueva Chuquihuanca, et al.
Published: (2024-04-01)